Inhibition Of Hypoxia Inducible Factor 1 Alpha Expression Suppresses The Progression Of Esophageal Squamous Cell Carcinoma

Hong Zhu,Yadong Feng,Jie Zhang,Xiqiao Zhou,Bo Hao,Guoxin Zhang,Ruihua Shi
DOI: https://doi.org/10.4161/cbt.11.11.15707
2011-01-01
Cancer Biology & Therapy
Abstract:Hypoxia inducible factor 1 alpha (HIF-1 alpha) is highly expressed and is implicated in the progression of esophageal squamous cell carcinoma. To investigate the potential mechanism by which HIF-1 alpha contributes to the progression of esophageal squamous cell carcinoma, here we established stable esophageal carcinoma cell lines Eca-109 and TE-13 in which HIF-1 alpha was depleted by shRNA mediated gene silencing. In addition, we used specific inhibitor YC-1 to inhibit HIF-1 alpha expression. Our in vitro studies demonstrated that shRNA or chemical mediated inhibition of HIF-1 alpha led to reduced proliferation and increased apoptosis of esophageal carcinoma cells, as well as the downregulatuion of HIF-1 alpha targets VEGF, MMP2 and BCL2. Furthermore, we employed xenograft nude mice model to validate the in vitro findings and proved that depletion of HIF-1 alpha suppressed the tumorigenicity of esophageal carcinoma cells in vivo. In conclusion, our results provide new insight into the potential role of HIF-1 alpha in esophageal squamous cell carcinoma and open up the possibility of inhibiting HIF-1 alpha for targeted therapy of esophageal squamous cell carcinoma.
What problem does this paper attempt to address?